{
    "code": "02024215",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024215",
    "time": "2019-07-05 03:03:55",
    "許可證字號": "衛署藥輸字第024215號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/04\/29",
    "發證日期": "94\/04\/29",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202421507",
    "中文品名": "山喜多膜衣錠500毫克",
    "英文品名": "CELLCEPT F.C. TABLETS 500MG",
    "適應症": "與cyclosporin和類固醇合併使用，以預防或緩解腎臟移植之急性器官排斥、預防心臟和肝臟移植之急性器官排斥。\r\n與皮質類固醇合併使用，Cellcept適用於在患有International Society of Nephrology\/Renal Pathology Society (ISN\/RPS)第III、第IV或第V類狼瘡性腎炎(lupus nephritis)的成人病人中作為前導及維持治療。",
    "劑型": "116膜衣錠",
    "包裝": "8-1000粒鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "MYCOPHENOLATE MOFETIL",
    "主製造廠": {
        "申請商名稱": "1901701100  羅氏大藥廠股份有限公司",
        "申請商地址": "台北市松山區民生東路三段１３４號９樓",
        "主製造廠": "",
        "製造廠名稱": "FIT0463100  Delpharm Milano S.r.l."
    },
    "CCC號列": "30049091001 抗排斥醫藥製劑Immunosuppressive preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FCH0208000  F.HOFFMANN-LA ROCHE LTD.",
            "製造廠廠址": "WURMISWEG, CH-4303 KAISERAUGST, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "包裝及分裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200036200",
            "成分名稱": "MYCOPHENOLATE MOFETIL",
            "含量描述": "",
            "含量": "500.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "CellCept_仿單核定本1080528-108-05-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024215&Seq=028&Type=9"
        },
        {
            "title": "carton-108-05-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024215&Seq=001&Type=8"
        }
    ]
}